Medindia
Medindia LOGIN REGISTER
Advertisement

Systech Participates in Exclusive Seminar Series Organized by U.S. Consulates in India

Friday, March 24, 2017 Indian Health News
Advertisement
Topics Include Risk Mitigation in the Indian Pharmaceutical Industry, the Criticality of Protecting U.S. Exports and Fighting Counterfeits in the Supply Chain
Advertisement

MUMBAI, India, March 24, 2017 /PRNewswire/ -- Systech International, a global technology solutions leader and innovator in serialization for the pharmaceutical industry, recently participated in a series of seminars organized by the United States Department of Commerce and the Consulate Generals of Hyderabad, Ahmedabad, and Mumbai. The Single Company Promotion (SCP) seminar program created by the Commerce Department showcases and advances the best technologies developed in the United States to Indian executives from a variety of industries. Over 80 senior executives representing more than 35 companies attended the invitation-only series from February 28-March 2, 2017.
Advertisement

Systech was selected as a presenting company because it offers mission-critical solutions to the Indian pharmaceutical market in two focused areas—regulatory compliance and anti-counterfeiting. The seminars offered the most current knowledge, best practices, and a complete end-to-end solution for total compliance with the U.S. Drug Supply Chain Security Act (DSCSA), a secure supply chain, and the ability to protect a company's brand anytime, anywhere on the globe.

Dr. Avi Chaudhuri, Senior Global Partner, presented the keynote sessions on Systech's technology solutions. According to Chaudhuri, "We were there to inform companies about the necessity of deploying serialization for global Track & Trace mandates, as well as to present best practices for complying within stated timeframes. Our presentation also included information about the shortcomings of serialization, as a consumer-driven authentication tool for brand protection, and how Systech's new anti-counterfeiting solution can address this issue for the Indian domestic market. Our non-additive technology solution, which cannot be replicated by counterfeiters, provides companies with a powerful new method for brand protection, as well as a complement to a company's consumer engagement activities."

Systech is the global leader in the field of serialization and traceability, with a 30-year history providing vision solutions to the pharmaceutical industry. Its vision systems also provide the company with an innovative solution to protect brands and deter counterfeiters, regardless of industry. In addition to Dr. Chaudhuri's presentations, other presenters included Arun Gupta, former global CIO of Cipla, who spoke on how to successfully leverage information technology and validating a seamless solution; and Ranga Iyer, former Managing Director of Wyeth and past President of the Organisation of Pharmaceutical Producers of India (OPPI), who moderated attendee discussion sessions.

About Systech International Systech, a global leader in product verification and brand protection, is re-defining the future of authentication. As the innovator of serialization, Systech is trusted by top pharmaceutical companies worldwide to ensure regulatory compliance, mitigate risk, ensure supply chain integrity, and drive efficiency. Beyond compliance, the company is leading the charge to protect global brands—for consumer packaged goods, food & beverage, health & beauty, pharmaceutical, and contract manufacturing companies. Its best practices and award-winning technologies are guiding Product and Brand Protection Officers in their quest to improve patient/consumer safety, increase engagement, decrease counterfeiting, avoid diversion, and reduce harm to coveted brands. For more information visit www.systechone.com.

SYSTECH CONTACTErin DunkelVice President, Marketing+1 (610) [email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Indian Health News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close